HPV-associated diseases: questions and answers

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum. 2012; 100(PtB): 1-441.
2. Каприн А.Д., Старинский В.В., Шахзадова А.О., ред. Состояние онкологической помощи населению России в 2019 году. М.; 2020. [Kaprin A.D., Starinsky V.V., Shakhzadova A.O., ed. State of oncological assistance to the population of Russia in 2019. M.; 2020. (in Russian)].
3. Bruni L., Albero G., Serrano B., Mena M., Collado J.J. et al. IARC/ICO Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in Russian Federation. Summary Report 22 October 2021. [Электронный ресурс] Available at: http://www.hpvcentre.net/statistics/reports/RUS.pdf?t=1548009998402
4. Грецова О.П., Костин А.А., Самсонов Ю.В., Петрова Г.В., Простов М.Ю., Простов Ю.И. Заболеваемость и смертность от злокачественных новообразований, ассоциированных с вирусом папилломы человека. Исследования и практика в медицине. 2017; 4(3): 33-50. [Gretsova O.P., Kostin A.A., Samsonov Yu.V., Petrova G.V., Prostov M.Yu., Prostov Yu.I. Morbidity and mortality from malignant neoplasms associated with human papillomavirus. Research’n Practical Medicine Journal. 2017; 4(3): 33-50. (in Russian)]. https://dx.doi.org/10.17709/2409-2231-2017-4-3-4.
5. Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 2021; 70(4): 1-187. https://dx.doi.org/10.15585/mmwr.rr7004a1.
6. WHO. Global health sector strategy on sexually transmitted infections 2016–2021 towards ending STIS (document WHA69/2016/REC/1).
7. Rowley J., Vander Hoorn S., Korenromp E., Low N., Unemo M., Abu-Raddad L.J. et al. Global and regional estimates of the prevalence and incidence of four curable sexually transmitted infections in 2016. WHO Bulletin. June 2019.
8. Прилепская В.Н., Сухих Г.Т., ред. Диагностика, лечение и профилактика цервикальных интраэпителиальных неоплазий. М.: МЕДпресс-информ; 2020. 80с. [Prilepskaya V.N., Sukhikh G.T., ed. Diagnosis, treatment and prevention of cervical intraepithelial neoplasias. M.: MEDPress-inform; 2020. 80 p. (in Russian)].
9. Довлетханова Э.Р., Прилепская В.Н. Дифференцированная тактика ведения пациенток с ВПЧ-ассоциированными заболеваниями гениталий. Акушерство и гинекология. 2015; 10: 118-24. [Dovletkhanova E.R., Prilepskaya V.N. A differentiated approach to treating papillomavirus-associated genital diseases in women. Obstetrics and Gynecology. 2015; 10: 118-24. (in Russian)].
10. Гусаков К.И., Назарова Н.М., Прилепская В.Н., Стародубцева Н.Л., Франкевич В.Е. Перспективы профилактики рака, ассоциированного с вирусом папилломы человека. Акушерство и гинекология. 2019; 8: 33-9. [Gusakov K.I., Nazarova N.M., Prilepskaya V.N., Starodubtseva N.L., Frankevich V.E. Prospects for the prevention of HPV-associated cancer. Obstetrics and Gynecology. 2019; 8: 33-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.8.33-39.
11. Ribeiro A.L., Caodaglio A.S., Sichero L. Regulation of HPV transcription. Clinics (Sao Paulo). 2018; 73(Suppl. 1): e486s. https://dx.doi.org/10.6061/clinics/2018/e486s.
12. Egawa N., Doorbar J. The low-risk papillomaviruses. Virus Res. 2017; 231: 119-27. https://dx.doi.org/10.1016/j.virusres.2016.12.017.
13. Koliopoulos G., Nyaga V.N., Santesso N., Bryant A., Martin-Hirsch P.P., Mustafa R.A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017; 8(8): CD008587. https://dx.doi.org/10.1002/14651858.CD008587.pub2.
14. Bhatla N., Singhal S. Primary HPV screening for cervical cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 65: 98-108. https://dx.doi.org/10.1016/j.bpobgyn.2020.02.008.
15. Medeiros R., Vaz S., Rebelo T., Figueiredo-Dias M. Prevention of human papillomavirus infection. Beyond cervical cancer: a brief review. Acta Med. Port. 2020; 33(3): 198-201. https://dx.doi.org/10.20344/amp.12259.
16. Генитальная ВПЧ-инфекция — информационный бюллетень центра по контролю и профилактике заболеваний, CDC, USA [электронный ресурс]. [Global health sector strategy on sexually transmitted infections 2016–2021 towards ending STIS (document WHA69/2016/REC/1)]. Available at: https://www.cdc.gov/std/russian/stdfact-hpv-russian.htm
17. Jain M.A., Limaiem F. Cervical intraepithelial squamous cell lesion. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
18. Brianti P., De Flammineis E., Mercuri S.R. Review of HPV-related diseases and cancers. New Microbiol. 2017; 40(2): 80-5.
19. Ngo-Metzger Q., Adsul P. Screening for cervical cancer. Am. Fam. Physician. 2019; 99(4): 253-4.
20. Nayar R., Wilbur D.C. The Bethesda system for reporting cervical cytology: a historical perspective. Acta Cytol. 2017; 61(4-5): 359-72. https://dx.doi.org/10.1159/000477556.
21. Министерство здравоохранения Российской Федерации. Письмо Министерства здравоохранения РФ от 2 ноября 2017 г. N 15-4/10/2-7676. О направлении клинических рекомендаций (протокола лечения) «Доброкачественные и предраковые заболевания шейки матки с позиции профилактики рака». [Ministry of Health of the Russian Federation. Letter of the Ministry of Health of the Russian Federation dated November 2, 2017 N 15-4/10/2-7676. On the direction of clinical recommendations (treatment protocol) "Benign and precancerous cervical diseases from the perspective of cancer prevention." (In Russian)].
22. Sawaya G.F., Smith-McCune K., Kuppermann M. Cervical cancer screening: More choices in 2019. JAMA. 2019; 321(20): 2018-9. https://dx.doi.org/10.1001/jama.2019.4595.
23. Гусаков К.И., Назарова Н.М., Франкевич В.Е., Стародубцева Н.Л., Бурменская О.В., Прилепская В.Н., Сухих Г.Т. Результаты генотипирования вируса папилломы человека у женщин репродуктивного возраста, вакцинированных от вируса папилломы человека. Акушерство и гинекология. 2020; 9: 114-9. [Gusakov K.I., Nazarova N.M., Frankevich V.E., Starodubtseva N.L., Burmenskaya O.V., Prilepskaya V.N., Sukhikh G.T. Human papillomavirus genotyping results of human papillomavirus vaccinated women of reproductive age. Obstetrics and Gynecology. 2020; 9: 114-9. (in Russiab)]. https://dx.doi.org/10.18565/aig.2020.9.114-119.
24. Chrysostomou A.C., Stylianou D.C., Constantinidou A., Kostrikis L.G. Cervical cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing. Viruses. 2018; 10(12): 729. https://dx.doi.org/10.3390/v10120729.
25. Darragh T.M., Colgan T.J., Cox J.T., Heller D.S., Henry M.R., Luff R.D. et al.; Members of LAST Project Work Groups. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch. Pathol. Lab. Med. 2012; 136(10): 1266-97. https://dx.doi.org/10.5858/arpa.LGT200570. Erratum in: Arch. Pathol. Lab. Med. 2013; 137(6):738.
26. Tatti S., Bornstein J., Prendiville W. Colposcopy: a global perspective: introduction of the new IFCPC colposcopy terminology. Obstet. Gynecol. Clin. North Am. 2013; 40(2): 235-50. https://dx.doi.org/10.1016/j.ogc.2013.02.002. ​
27. Жирарди Ф., Райх О., Тамуссино К., Пикель Х. Кольпоскопия и патология шейки матки по Бургхардту; Пер. с англ. Прилепская В.Н., ред. М.: МЕДпресс-информ; 2018. 224с. [Girardi F., Reich O., Tamussino K., Pikel H. Burghardt's colposcopy and cervical pathology; transl from English [E.V. Kovalev], V.N. Prilepskaya, eds. M.: MEDPress-inform; 2018. 224 p. (in Russian)].
28. Khan M.J., Werner C.L., Darragh T.M., Guido R.S., Mathews C., Moscicki A.B. et al. ASCCP colposcopy standards: role of colposcopy, benefits, potential harms, and terminology for colposcopic practice. J. Low. Genit. Tract. Dis. 2017; 21(4): 223-9. 10. https://dx.doi.org/1097/LGT.0000000000000338.
29. Bornstein J., Bentley J., Bösze P., Girardi F., Haefner H., Menton M. et al. 2011 Colposcopic terminology of the international federation for cervical pathology and colposcopy. Obstet. Gynecol. 2012; 120(1): 166-72. https://dx.doi.org/10.1097/AOG.0b013e318254f90c.
30. IFCPC 2017 World Congress for Cervical Pathology and Colposcopy. April 4-7, 2017, Orlando, Florida; 2017.
31. Korostil I., Ali H., Guy R., Donovan B., Law M.G., Regan D.G. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Sex. Transm. Dis. 2013; 40(11): 833-5. https://dx.doi.org/10.1097/OLQ.0000000000000030.
32. Kovachev S.M. A review on inosine pranobex immunotherapy for cervical HPV-positive patients. Infect. Drug Resist. 2021; 14: 2039-49. https://dx.doi.org/10.2147/IDR.S296709.
33. Sliva J., Pantzartzi C.N., Votava M. Inosine pranobex: a key player in the game against a wide range of viral infections and non-infectious diseases. Adv. Ther. 2019; 36(8): 1878-905. https://dx.doi.org/10.1007/s12325-019-00995-6.
34. D'Alessandro P., Arduino B., Borgo M., Saccone G., Venturella R., Di Cello A., Zullo F. Loop electrosurgical excision procedure versus cryotherapy in the treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of randomized controlled trials. Gynecol. Minim. Invasive Ther. 2018; 7(4): 145-51. https://dx.doi.org/10.4103/GMIT.GMIT_56_18.
35. Дикке Г.Б. Современные подходы к вторичной профилактике рака шейки матки. Акушерство и гинекология. 2018; 4: 131-7. [Dikke G.B. Modern approach in secondary preventive measures in treatment of cervical cancer. Obstetrics and Gynecology. 2018; 4: 131-7. (in Russian). https://dx.doi.org/10.18565/aig.2018.4.131-137.
36. Прилепская В.Н., Новикова Е.П., Суламанидзе Л.А., Мзарелуа Г.М. Папилломавирусная инфекция. Возможности лечения и профилактики с применением инозин пранобекса. Акушерство и гинекология. 2013; 10: 99-103. [Prilepskaya V.N., Novikova E.P., Sulamanidze L.A., Mzarelua G.M. Papillomavirus infection. Possibilities for the treatment and prevention with inosine pranobex. Obstetrics and Gynecology. 2013; 10: 99-103. (in Russian)].
37. Абакарова П.Р., Прилепская В.Н. ВПЧ-ассоциированные заболевания шейки матки. Возможности комплексной терапии. Гинекология. 2017; 19(5): 4-9. [Abakarova P.R., Prilepskaya V.N. HPV-associated diseases of the cervix. Complex therapy options. Gynecology. 2017; 19(5): 4-9. (in Russian)]. https://dx.doi.org/10.26442/2079-5696_19.5.4-9.
38. Бурменская О.В., Назарова Н.М., Сычева Е.Г., Прилепская В.Н., Трофимов Д.Ю., Сухих Г.Т. Применение молекулярно-генетических методов для диагностики и прогноза развития дисплазии тяжелой степени и рака шейки матки. Акушерство и гинекология. 2021; 10: 85-92. [Burmenskaya O.V., Nazarova N.M., Cysheva E.G., Prilepskaya V.N., Trofimov D.Yu., Sukhikh G.T. Application of molecular genetic methods for the diagnosis and prediction of severe dysplasia and cervical cancer. Obstetrics and Gynecology. 2021; 10: 85-92. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.10.
39. Гаспарян С.А., Овчинникова О.С. Оптимизация противовирусной терапии инозин пранобексом начальных поражений ВПЧ-ассоциированных заболеваний шейки матки. Акушерство и гинекология. 2015; 9: 94-7. [Gasparyan S.A., Ovchinnikova O.S. Optimization of antiviral therapy with inosine pranobex for early injuries due to HPV-associated diseases of the cervix uteri. Obstetrics and gynecology. 2015; 9: 94-7. (in Russian)].

Received 10.10.2021

Accepted 10.11.2021